C
Camille Legeai
Researcher at French Institute of Health and Medical Research
Publications - 65
Citations - 1112
Camille Legeai is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 14, co-authored 44 publications receiving 682 citations.
Papers
More filters
Journal ArticleDOI
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.
Kitty J Jager,Anneke Kramer,Nicholas C. Chesnaye,Cécile Couchoud,J. Emilio Sánchez-Álvarez,Liliana Garneata,Frederic Collart,Marc H Hemmelder,Patrice M. Ambühl,Julia Kerschbaum,Camille Legeai,María Dolores del Pino y Pino,Gabriel Mircescu,Lionel Mazzoleni,Tiny Hoekstra,Rebecca Winzeler,Gert Mayer,Vianda S. Stel,Christoph Wanner,Carmine Zoccali,Ziad A. Massy +20 more
TL;DR: The pandemic has had a substantial effect on mortality in patients receiving kidney replacement therapy; a highly vulnerable population due to underlying chronic kidney disease and high prevalence of multimorbidity.
Journal ArticleDOI
IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT).
Olivier Thaunat,Olivier Thaunat,Camille Legeai,Dany Anglicheau,Lionel Couzi,Gilles Blancho,Marc Hazzan,Myriam Pastural,Emilie Savoye,Florian Bayer,Emmanuel Morelon,Emmanuel Morelon,Yann Le Meur,Olivier Bastien,Sophie Caillard,Charlene Levi,Fanny Buron,Alice Koenig,Thomas Barba,Bruno Moulin,Samira Fafi-Kremer,Anglicheau Dany,Alexandre Hertig,Jérôme Tourret,Benoit Barrou,Pierre Merville,Anna Kaminski,Valérie Moal,Tristan Legris,Pierre François Westeel,Maïté Jauréguy,Luc Frimat,Didier Ducloux,Jamal Bamoulid,Dominique Bertrand,Michel Tsimaratos,Florentine Garaix-Gilardo,Jérôme Dumortier,Sacha Mussot,Antoine Roux,L. Sebbag,Yannick Le Meur,Christophe Masset,Nassim Kamar,Hélène François,Eric Rondeau,Nicolas Bouvier,Christiane Mousson,Matthias Büchler,Philippe Gatault,Jean-François Augusto,Agnès Duveau,Cécile Vigneau,Marie Christine Morin,Jonathan M. Chemouny,Leonard Golbin,Philippe Grimbert,Marie Matignon,Antoine Durrbach,Clarisse Greze,Renaud Snanoudj,Charlotte Colosio,Betoul Schvartz,Paolo Malvezzi,Christophe Mariat,Antoine Thierry,Moglie Le Quintrec,Antoine Sicard,Jean Philippe Rerolle,Anne Elisabeth Heng,Cyril Garrouste,Henri Vacher Coponat,Eric Epailly,Olivier Brugière,Sébastien Dharancy,Éphrem Salame,Faouzi Saliba +76 more
TL;DR: In case of a second epidemic wave, kidney transplantation should be suspended in high viral risk areas but maintained outside those areas, both to reduce the excess of deaths of candidates and avoid wasting precious resources.
Journal ArticleDOI
Adult male circumcision as an intervention against HIV: An operational study of uptake in a South African community (ANRS 12126)
Pascale Lissouba,Dirk Taljaard,Dino Rech,Veerle Dermaux-Msimang,Camille Legeai,David A. Lewis,David A. Lewis,Beverley Singh,Adrian Puren,Adrian Puren,Bertran Auvert +10 more
TL;DR: It is suggested that AMC roll-out is promising but requires careful implementation strategies to be successful against the African HIV epidemic and communication and counseling should emphasize what clinical AMC is and its effect on HIV acquisition.
Journal ArticleDOI
The HIV/AIDS epidemic in Cuba: description and tentative explanation of its low HIV prevalence
Hector de Arazoza,Jose Joanes,Rachid Lounes,Camille Legeai,Stéphan Clémençon,Jorge Pérez,Bertran Auvert,Bertran Auvert +7 more
TL;DR: To reduce the HIV epidemic in Cuba, the epidemic among MSM should be addressed and the Cuban policy, based on intensive HIV testing and tracing of partners, may be considered as a possible policy to control HIV/AIDS epidemics in other countries.
Journal ArticleDOI
Benefits of kidney transplantation for a national cohort of patients aged 70 years and older starting renal replacement therapy.
Camille Legeai,Roland M Andrianasolo,Olivier Moranne,Renaud Snanoudj,Maryvonne Hourmant,Marc Bauwens,Joaquim Soares,Christian Jacquelinet,Cécile Couchoud,Marie-Alice Macher +9 more
TL;DR: Elderly kidney transplantation survival benefit in people aged ≥70 who were receiving renal replacement therapy (RRT) and their risk factors for posttransplant mortality were evaluated, including diabetes, cardiovascular comorbidities, and dialysis duration >2 years.